Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126439681 | 12643968 | 1 | I | 20160804 | 20160811 | 20160811 | EXP | GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-51448UK | BOEHRINGER INGELHEIM | 68.00 | YR | M | Y | 65.00000 | KG | 20160811 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126439681 | 12643968 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | N | 22512 | 150 | MG | ||||||||
126439681 | 12643968 | 2 | SS | VORICONAZOLE. | VORICONAZOLE | 1 | Unknown | U | 0 | ||||||||||
126439681 | 12643968 | 3 | C | ALENDRONIC ACID | ALENDRONIC ACID | 1 | Unknown | 0 | |||||||||||
126439681 | 12643968 | 4 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | Unknown | 0 | |||||||||||
126439681 | 12643968 | 5 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | 0 | |||||||||||
126439681 | 12643968 | 6 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Unknown | 0 | |||||||||||
126439681 | 12643968 | 7 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Unknown | 0 | |||||||||||
126439681 | 12643968 | 8 | C | TERBUTALINE | TERBUTALINE | 1 | Unknown | 0 | |||||||||||
126439681 | 12643968 | 9 | C | WARFARIN | WARFARIN | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126439681 | 12643968 | 1 | Atrial fibrillation |
126439681 | 12643968 | 2 | Bronchopulmonary aspergillosis |
126439681 | 12643968 | 3 | Product used for unknown indication |
126439681 | 12643968 | 4 | Product used for unknown indication |
126439681 | 12643968 | 5 | Product used for unknown indication |
126439681 | 12643968 | 6 | Product used for unknown indication |
126439681 | 12643968 | 7 | Product used for unknown indication |
126439681 | 12643968 | 8 | Product used for unknown indication |
126439681 | 12643968 | 9 | Atrial fibrillation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126439681 | 12643968 | OT |
126439681 | 12643968 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126439681 | 12643968 | Blood blister | |
126439681 | 12643968 | Coagulation time shortened | |
126439681 | 12643968 | Coagulopathy | |
126439681 | 12643968 | Contusion | |
126439681 | 12643968 | Drug interaction | |
126439681 | 12643968 | Haemorrhage subcutaneous | |
126439681 | 12643968 | Pain | |
126439681 | 12643968 | Skin disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126439681 | 12643968 | 1 | 20160701 | 20160722 | 0 | |
126439681 | 12643968 | 9 | 201606 | 0 |